The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versi ...

MILAN (Reuters) - Danish drugmaker Novo Nordisk's shares hit an over 9-month low on Thursday after surging more than 8% the previous day, as underwhelming guidance for next year overshadowed strong ...

The rush for weight loss drugs like Wegovy and diabetes drugs like Ozempic (which is also used for weight loss) has drained ...

Meanwhile, Novo Nordisk experiences a dip in stock value despite strong performances by its weight-loss drug, Wegovy. In ...

Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last ...